General Information
- Activity Dates: May 15-16, 2024
- Location: Mount Sinai Medical Center Miami, Florida
- Format: Live/In-person and Live Online
- Website: https://events.hubilo.com/the-summit-on-breakthrough-therapies-for-addiction
- Joint Provider: Aura CE, LLC
- Agenda: Click Here to View
This activity offers CE credit for:
- Physicians (AMA)
- Nurses (ANCC)
- Physician Assistants (AAPA)
- Social Workers (ASWB-ACE)
- Pharmacists (ACPE)
- Other
All other attendees will receive a Certificate of Attendance
Faculty
Jose Cruz, MD
Schottenstein Family Chair for Behavioral Health
Mount Sinai Medical Center
Caroline Elistin, DNP, MSN-Ed, AAPRN, FNP-BC, PMHNP-BC
Adjunct Professor, Doctorate of Nursing Practice
University of Miami
Miami, Florida
Charlie Panfil
Public Policy Advisor
The Daschle Group
Washington, DC
Elias Dakwar, MD
Associate Professor of Clinical Psychiatry
Columbia University School of Medicine
New York, New York
Jennifer L. Jones, MD
Assistant Professor
Medical University of South Carolina
Mount Pleasant, South Carolina
Lantie Jorandby, MD
Distinguished Fellow American Psychiatric Association
Chief Medical Officer
Lakeview Health
Jacksonville, Florida
Michelle Weiner, DO, MPH
Director of Integrative Pain Solutions
NeuroPain Health
Miami, Florida
Owen Muir, MD
Interventional Brain Medicine
NIH Research
The Frontier Psychiatrists
Brooklyn, New York
Peter Hendricks, PhD
Professor and Clinical Psychologist
University of Alabama at Birmingham
Birmingham, Alabama
Richard Seely, MD
Secretary
Florida Society of Addiction Medicine
Weston, Florida
Statement of Need
Persistent gaps in addiction treatment, including understanding co-occurring disorders, integrating pharmacotherapy effectively, and promoting cultural competence, underscore the need for an event focused on addiction treatments. Practitioners often lack knowledge in evidence-based practices, trauma-informed care, and stigma reduction. An event addressing these gaps would facilitate discussions to enhance addiction care, improving outcomes for individuals affected by addiction.
Learning Objectives
- Classify the current research status and evidence base for addiction treatments.
- Appraise proposed psychological and biological mechanisms of action for emerging therapies.
- Identify key stakeholders across research, industry, policy, and patient experience domains that must collaborate to advance new addiction treatment options.
- Assess challenges, limitations, and next steps needed in bringing breakthrough addiction treatments through clinical trials and FDA approval.
Financial Support
There is no commercial support associated with this educational activity.
Target Audience
Psychiatrists, primary care physicians, psychologists, nurse practitioners, physician assistants, psychiatric nurses, pharmacists, social workers, behavioral health professionals and other healthcare professionals who seek to improve the treatment of patients with mental health disorders.
Disclosures
All CME/CE activities may contain discussion of published research on uses of agents that are not yet approved by the FDA. Faculty of this CME/CE activity may NOT include discussions of treatment recommendations pertaining to products or devices that are not currently approved for use by the FDA.
The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of FDA approved products or devices. CME Outfitters, LLC, the faculty, planners, Momentum PBC and Aura CE do not endorse the use of any product outside of the FDA labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Accredited Agenda
Please note that there is content on the conference agenda before and after the accredited agenda shared below. To see the full conference agenda, please click here .
9:15 Opening Keynote Panel: The Current State of Breakthrough Therapies for Addiction
This session will examine emerging medicines and treatments that show promise in addressing substance use disorders, behavioral addictions, and co-occurring mental health conditions. We will analyze the current evidence, patient populations being studied, challenges still ahead, and the potential of these breakthroughs to transform outcomes if brought to market. Attendees will gain insight into the therapies farthest along in development and how they may expand available options for treating addiction in the years ahead.
Jose Cruz, MD
Chairman, Department of Behavioral Medicine
Schottenstein Family Chair for Behavioral Health
Mount Sinai Medical Center
Caroline Elistin, DNP, MSN-Ed, AAPRN, FNP-BC, PMHNP-BC
Adjunct Professor, Doctorate of Nursing Practice
University of Miami
Richard Seely, MD
Secretary
Florida Society of Addiction Medicine
*This session qualifies for CME accreditation.
10:15 Unraveling The Relationship Between Pain and Addiction
Clinical trials for addictions and chronic pain often exclude participants with overlapping conditions, leaving a critical gap in understanding the interplay between pain and addiction. This session delves into the underappreciated connection between these two prevalent issues. By addressing the profound relationship between pain and addiction, we can develop more comprehensive strategies for assisting individuals in their recovery journey. Failing to address the root pain, whether emotional or physical, that initially led individuals to seek drugs can hinder the effectiveness of addiction treatment.
Michelle Weiner, DO, MPH
Director of Integrative Pain Solutions
NeuroPain Health
*This session qualifies for CME accreditation.
11:00 Morning Break
11:30 Non-accredited Session
12:00 Non-accredited Session
12:45 Lunch Break
2:00 Efficacy of Ketamine in the Treatment of Substance Use Disorders
Ketamine has shown preliminary promise as a rapid-acting antidepressant. Now, a growing body of research is exploring ketamine’s potential in treating addiction as well. In this session, leading experts will review mounting evidence surrounding ketamine-assisted therapy for substance use disorders. They will discuss proposed mechanisms of action, results from clinical trials, ideal patient profiles, implementation considerations, and next steps in evaluating ketamine’s efficacy as an addiction treatment.
Elias Dakwar, MD
Associate Professor of Clinical Psychiatry
Columbia University School of Medicine
Jennifer L. Jones, MD
Assistant Professor
Medical University of South Carolina
*This session qualifies for CME accreditation.
2:45 Psilocybin: A Promising Approach to Addiction Treatment
Psilocybin has demonstrated significant potential in recent clinical trials as an adjunct to psychotherapy for addiction. This session will showcase the research and evidence surrounding psilocybin for addiction treatment.
Peter Hendricks, PhD
Professor and Clinical Psychologist
University of Alabama at Birmingham
*This session qualifies for CME accreditation.
3:30 Exploring the Future of Breakthrough Therapies for Addiction: Research, Applications, and Scalability
This discussion will explore the evolving landscape of breakthrough addiction therapies. Throughout this session, we’ll delve into recent advancements and future prospects in addiction treatment. Our discussion will highlight the latest developments in pharmaceuticals and digital interventions, demonstrating their potential to revolutionize addiction care. Thought leaders will share insights on advancing research, refining practical implementations, and amplifying the impact of transformative approaches.
Lantie Jorandby, MD
Distinguished Fellow American Psychiatric Association
Chief Medical Officer
Lakeview Health
Peter Hendricks, PhD
Professor and Clinical Psychologist
University of Alabama at Birmingham
Charlie Panfil
Public Policy Advisor
The Daschle Group
Moderator:
Owen Muir, MD
Interventional Brain Medicine
NIH Research
The Frontier Psychiatrists
*This session qualifies for CME accreditation.
Credit Information
In support of improving patient care, this activity has been planned and implemented by Aura CE, LLC and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designations
Physicians (ACCME)
CME Outfitters, LLC, designates this Live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
Nurses (ANCC)
This activity is designated for 4.0 contact hours.
Physician Associates (AAPA)
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
All other healthcare professionals may receive a Certificate of Participation stating this activity was certified for AMA PRA Category 1 Credit™.
Pharmacists (ACPE)
This knowledge-based activity is approved for 4.0 contact hours (0.4 CEUs) of continuing pharmacy credit (UAN JA 0007185-9999-24-061-L01-P).
Social Workers (ASWB-ACE)
As a Jointly Accredited Organization, CME Outfitters, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. CME Outfitters, LLC maintains responsibility for this course. Social workers completing this course receive 4.0 beginner continuing education credits.
Disclosure Declaration
All CME/CE activities may contain discussion of published research on uses of agents that are not yet approved by the FDA. Faculty of this CME/CE activity may NOT include discussions of treatment recommendations pertaining to products or devices that are not currently approved for use by the FDA.
The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of FDA approved products or devices. CME Outfitters, LLC, the faculty, planners, Momentum PBC and Aura CE do not endorse the use of any product outside of the FDA labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. Relevant financial relationships exist between the following individuals and commercial interests:
Faculty:
Owen Muir, MD discloses Grants: National Institute of Mental Health, iRxReminder. LLC; Research Support: Mind Medicine Inc., Magnus Medical; Consultant: Magnus Medical; Soniera Bio; Brainfutures; US Department of Justice; Janssen (2021); Sanm.ai; Stock Shareholder (directly purchased): Brainsway; Mindmed
Peter Hendricks discloses Grants: Diamond Therapeutics Inc., National Institutes of Health/National Institute on Drug Abuse, Beckley Psytech Ltd.; Consultant: Bright Minds Biosciences, Inc., Eleusis Health Solutions (acquired by Beckley PsyTech), Journey Colab, Reset Pharmaceuticals; Stock Shareholder (directly purchased): co-founder of Mycelial Health and Equulus Therapeutics
Michelle Weiner, DO, MPH discloses Other Financial or Material Support: Clinical Lead Advisor to Iter Investments (Fund closed in 2024)
Ben Greenzweig, Alon Weizer, MD, MS, Richard Seely, Caroline Elistin, Lantie Jorandby, Charlie Panfil, Elias Dakwar, Jose Cruz, and Jennifer L. Jones have nothing to disclose.
Planning Committee:
Benjamin Greezweig, Raquel Guzman, Derandoria Young, LCSW, Samuel Grodofsky, MD, Taylor Andrews Flatt, MSN, PMHNP-BC, CRNP, Sa’ed Al-Olimat, Pharm.D Candice Gillet, MPH have nothing to disclose.
Content Reviewer:
Scott J. Hershman MD, FACEHP, CHCP has nothing to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
*All relevant financial relationships have been mitigated.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, and Aura CE, LLC do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Credit Claiming and Evaluation Information:
At the end of the course, you will be provided with the activity’s evaluation, and print your certificate or statement of credit.
Credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately. This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy
Questions about this activity?
For questions before or after the activity, please contact Raquel Guzman at raquel@momentumevents.com. For questions during the activity, please contact Maggie Banchs at maggie@momentumevents.com.